0001493152-21-010065.txt : 20210429 0001493152-21-010065.hdr.sgml : 20210429 20210429175529 ACCESSION NUMBER: 0001493152-21-010065 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210203 FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deutsch Corey CENTRAL INDEX KEY: 0001843944 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 21872561 MAIL ADDRESS: STREET 1: POST OFFICE BOX NO. 1 STREET 2: HARBOR POINT ROAD CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 800 THIRD AVENUE, SUITE 2800 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 3/A 1 ownership.xml X0206 3/A 2021-02-03 2021-02-05 0 0000948320 LifeMD, Inc. LFMD 0001843944 Deutsch Corey C/O LIFEMD, INC., 800 THIRD AVENUE, SUITE 2800 NEW YORK, NY 10022 0 1 0 0 Chief Business Officer Common Stock 48630 D Options to purchase shares of Common Stock Common Stock, par value $0.001 25000 D Options to purchase shares of Common Stock Common Stock, par value $0.001 175000 D This Form 3 amendment is being filed to correct the number of shares directly owned Mr. Deutsch as of February 3, 2021. Previously filed Form 3/A on April 29, 2021 was erroneously filed with a scriveners error related to the date Mr. Deutsch purchased such shares. The shares were purchased by Mr. Deutsch on November 19, 2020, in a private placement offering by the Company. On February 3, 2021 (the "Effective Date"), Mr. Deutsch and the Issuer entered into First Amendment to Employment Agreement (the "Amended Employment Agreement"), whereby Mr. Deutsch was appointed Chief Business Officer of the Issuer. As of the Effective Date, the Board of Directors of the Issuer has acknowledged the role of Chief Business Officer as an executive officer position. Pursuant to the terms of the consulting agreement, by and between Mr. Deutsch and the Issuer, dated December 3, 2020, Mr. Deutsch was granted stock options to purchase up to 25,000 shares of the Company's common stock at an exercise price of $8.25 per share (the "Consultancy Stock Options"). The Consultancy Stock Options vested on December 3, 2020. Pursuant to the terms of the employment agreement, by and between Mr. Deutsch and the Issuer, dated January 14, 2021, Mr. Deutsch was granted stock options to purchase up to 175,000 shares of the Company's common stock at an exercise price of $7.07 per share (the "Stock Options"). The Stock Options shall vest in equal monthly tranches, based on the passage of time, over the 36 months, beginning on the Effective Date. /s/ Corey Deutsch 2021-04-29